Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluation of Cerebrospinal Fluid α‐Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome

Movement Disorders(2024)10.1002/mds.30019Source: DataRank Database

Evaluation of Cerebrospinal Fluid α‐Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome is a research paper published in Movement Disorders (2024). On theSindex it has a DataRank of 0. It has been cited 28 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access28 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 7.73)OA: hybridTopics (51)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (24)

Riona Fumi ORCID,Marte Theilmann Jensen ORCID,Megan Hodgson,Tatiana Georgiades ORCID,Lesley Wu ORCID

Live enrichment

PubMed:39301998 PMC:PMC11657022 OpenAlex:https://openalex.org/W4402681954

National Institute for Health Research (NIHR)

Grant: NIHR203312

Intramural NIH HHS

Grant: ZIA AG000546

UK Research and Innovation

Grant: MR/T033371/1

MICA: Dementias Platform UK 2 - Integrated Dementia Experimental Medicine

UK Research and Innovation

Grant: MR/Y008219/1

Early assessment, diagnosis and treatment of Parkinson's Plus Related Syndromes (ExPRESS)

National Institutes of Health Center for Alzheimer's and Related Dementias

Medical Research Council

CBD Solutions

PSP Association

Medical Research Council

CBD Solutions

National Institutes of Health Center for Alzheimer's and Related Dementias

FWCI

7.73

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30019

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30019

publisherhttps://movementdisorders.onlinelibrary.wiley.com/doi/pdf/10.1002/mds.30019

journalhttps://doi.org/10.1002/mds.30019

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39301998

Fields of Study

Parkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsTranscranial Magnetic Stimulation Studies03 medical and health sciences0302 clinical medicineHumansSupranuclear Palsy, Progressivealpha-SynucleinFemaleMaleAgedMiddle AgedCorticobasal DegenerationBiomarkersAged, 80 and over

MeSH Terms

Corticobasal DegenerationAgedAged, 80 and overFemaleHumansMaleMiddle AgedSupranuclear Palsy, ProgressiveBiomarkersalpha-Synuclein

Keywords

Progressive supranuclear palsyCorticobasal degenerationCerebrospinal fluidPathologyParkinson's diseaseBiomarkerPathologicalMedicineInternal medicineGastroenterologyDiseaseBiologyDiagnosisNeuropathologyTauopathiesSynucleinopathiesMaleAged, 80 and overBrief Reportalpha-SynucleinHumansFemaleSupranuclear Palsy, ProgressiveMiddle AgedBiomarkersAged